Oklahoma researchers interested in limiting equine herpesvirus (EHV) disease outbreaks have established specific dosing recommendations for the antiviral agent valacyclovir. The drug appears to be effective in preventing or minimizing clinical signs of the disease, but this success will be expensive for its users. Continue reading…









